You are here: Industry Insights > lupin

News List

Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2) biospectrumasia
June 05, 2019
Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep facility (Unit-2), by the Pharmaceutical and Medical Devices Agency (PMDA), Japan.
Lupin wins Packaging Award for ‘Lupin Sahayak’ expressbpd
May 31, 2019
‘Lupin Sahayak’ is a new patient’s awareness initiative byLupin’s Synox Team, that focuses on diabetes and hypertension
Lupin wins India Packaging Award for ‘Corcal Bone & Beauty’ expressbpd
May 30, 2019
Corcal is the latest launch by the company’s Consumer Healthcare Business, LupinLife
Lupin launches Budesonide Inhalation Suspension expressbpd
May 30, 2019
Lupin’s Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampules is a generic version of AstraZeneca Pharmaceuticals LP’s Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL
Lupin launches generic seizure drug in US expressbpd
May 13, 2019
The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Food and Drug Administration
Lupin and Aptissen announce exclusive distribution agreement of Synolis VA for Canada firstwordpharma
May 10, 2019
Lupin Limited (Lupin) and Aptissen S.A. (Aptissen) announced that they have entered into a definitive distribution agreement under which Aptissen has granted Lupin the exclusive rights to market, distribute and sell the current Aptissen products in Canada
Lupin appoints Christine Mundkur as Independent Director expressbpd
April 03, 2019
She most recently served as Chief Executive Officer and non-voting Chairman of the Board of Directors for Impopharma Inc
Lupin’s Pune Biotech facility receives EU GMP clearance expressbpd
March 28, 2019
The GMP certification confirms that Lupin has a robust manufacturing facility that ensures consistent and controlled production as per EU quality standards.
Lupin, YL Biologics receive nod to market rheumatoid arthritis drug in Japan expressbpd
March 27, 2019
Biosimilar Etanercept is indicated to treat moderate to severe rheumatoid arthritis (RA) and juvenile idiopathic arthritis
Lupin, YL Biologics receive PMDA approval for Etanercept biosimilar in Japan biospectrumasia
March 26, 2019
The approval to treat moderate to severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis was received today

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page